Fahmeedah S Kamal, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: 052793 · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kamal’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A134411 · Current
Licensed to practise in California · since 2015 · expires 2028-09-30 · University of Missouri-Kansas City School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$107,106
Medicare paid this office $107,106 for 294 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $22,487 | $265 |
| Long return visit (40+ min) | 51 | $11,181 | $162 |
| Return visit (30+ min) | 70 | $10,653 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $9,879 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $9,317 | $106 |
See all 13 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $22,487 | $265 |
| Long return visit (40+ min) | 51 | $11,181 | $162 |
| Return visit (30+ min) | 70 | $10,653 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $9,879 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $9,317 | $106 |
| Hemodialysis procedure with physician evaluation | 53 | $5,316 | $63 |
| Dialysis procedure including 1 evaluation | 12 | $3,554 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,145 | $116 |
| New patient visit (45+ min) | 17 | $2,673 | $157 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,170 | $155 |
| Return visit (30+ min) | 27 | $2,106 | $64 |
| Long return visit (40+ min) | 13 | $1,825 | $122 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 12 | $221 | $18 |
Who their Medicare patients are
294 Original Medicare patients in 2024. Average age 72 · Under 65 19% · 85 and older 13% · Women 40% · Also on Medicaid 38% · Health risk score 4.70. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 55% · Heart failure 52% · Coronary heart disease 51% · Atrial fibrillation 36% · Depression 24% · Dementia 20% · Cancer 19% · Stroke 19% · COPD 17%.
The office billed $481,489, Medicare allowed $138,135 and paid $107,106; for 842 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 294 | 842 | 72 | 4.70 | $481,489 | $107,106 |
| 2023 | 336 | 971 | 72 | 4.41 | $520,809 | $115,990 |
| 2022 | 370 | 1,147 | 72 | 4.37 | $540,069 | $112,304 |
| 2021 | 342 | 1,099 | 72 | 3.68 | $543,132 | $119,484 |
| 2020 | 362 | 1,242 | 71 | 4.08 | $544,552 | $103,831 |
| 2019 | 371 | 875 | 72 | 3.84 | $310,181 | $77,286 |
| 2018 | 240 | 727 | 70 | 4.59 | $257,658 | $56,010 |
| 2017 | 269 | 688 | 69 | 4.23 | $239,782 | $54,219 |
| 2016 | 267 | 714 | 69 | 4.23 | $213,392 | $49,116 |
| 2015 | 251 | 600 | 68 | 3.94 | $215,817 | $48,105 |
| 2014 | 231 | 517 | 72 | 3.28 | $118,278 | $40,843 |
| 2013 | 113 | 254 | 72 | 2.23 | $42,695 | $18,042 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $21,833 | $270 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $15,176 | $73 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 16 | $14,511 | $322 |
| Long return visit (40+ min) | 39 | $7,347 | $120 |
| Return visit (30+ min) | 39 | $6,413 | $111 |
| Return visit (30+ min) | 57 | $6,273 | $83 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 46 | $5,423 | $118 |
| Hemodialysis procedure with physician evaluation | 41 | $4,659 | $66 |
| Dialysis procedure including 1 evaluation | 16 | $4,274 | $81 |
| New patient visit (45+ min) | 28 | $3,810 | $136 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,730 | $110 |
| Long return visit (40+ min) | 13 | $2,618 | $164 |
| New patient visit (60+ min) | 13 | $2,523 | $194 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $1,310 | $45 |
| Short return visit (20+ min) | 11 | $913 | $76 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $907 | $76 |
| Telehealth originating site facility fee | 26 | $741 | $21 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 16 | $465 | $29 |
2022: 19 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $19,211 | $271 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 111 | $15,247 | $65 |
| Long return visit (40+ min) | 68 | $10,890 | $115 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 14 | $8,669 | $321 |
| Return visit (30+ min) | 66 | $7,906 | $81 |
| Hemodialysis procedure with physician evaluation | 55 | $6,741 | $67 |
| Return visit (30+ min) | 33 | $5,130 | $117 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 61 | $4,180 | $35 |
| Dialysis procedure including 1 evaluation | 18 | $4,147 | $81 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 37 | $3,354 | $91 |
| Dialysis services, 1 physician visit per month (20 years or older) | 12 | $3,272 | $182 |
| Long return visit (40+ min) | 20 | $3,226 | $140 |
| New patient visit (45+ min) | 17 | $2,183 | $128 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,091 | $123 |
| Short return visit (20+ min) | 19 | $2,065 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,963 | $93 |
| Short return visit (20+ min) | 25 | $1,513 | $58 |
| Telehealth originating site facility fee | 31 | $1,126 | $20 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 11 | $365 | $33 |
2021: 17 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 25 | $18,896 | $332 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 75 | $15,505 | $66 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 33 | $15,452 | $276 |
| Return visit (30+ min) | 95 | $14,095 | $87 |
| Return visit (30+ min) | 48 | $8,144 | $115 |
| Long return visit (40+ min) | 31 | $5,267 | $135 |
| Dialysis procedure including 1 evaluation | 17 | $4,498 | $82 |
| Dialysis services, 1 physician visit per month (20 years or older) | 12 | $4,001 | $191 |
| Hemodialysis procedure with physician evaluation | 33 | $3,779 | $67 |
| Long return visit (40+ min) | 15 | $3,092 | $172 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 31 | $2,879 | $93 |
| New patient visit (60+ min) | 14 | $2,367 | $169 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,130 | $125 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 32 | $2,017 | $35 |
| Telehealth originating site facility fee | 46 | $1,449 | $21 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,195 | $75 |
| Short return visit (20+ min) | 11 | $715 | $55 |
2020: 18 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 94 | $16,226 | $65 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 27 | $15,053 | $221 |
| Dialysis procedure including 1 evaluation | 28 | $11,615 | $78 |
| Return visit (30+ min) | 100 | $10,217 | $62 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 15 | $6,434 | $257 |
| Return visit (30+ min) | 59 | $6,192 | $84 |
| Dialysis services, 1 physician visit per month (20 years or older) | 16 | $5,115 | $170 |
| Hemodialysis procedure with physician evaluation | 42 | $4,722 | $61 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 28 | $3,031 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,911 | $127 |
| New patient visit (45+ min) | 18 | $2,612 | $145 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 37 | $1,973 | $34 |
| Short return visit (20+ min) | 38 | $1,884 | $46 |
| Telehealth originating site facility fee | 56 | $1,576 | $21 |
| Long return visit (40+ min) | 15 | $1,431 | $95 |
| Long return visit (40+ min) | 11 | $1,365 | $124 |
| Short return visit (20+ min) | 19 | $1,067 | $53 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $947 | $73 |
2019: 16 services
| Return visit (30+ min) | 113 | $14,508 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 87 | $11,156 | $66 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $7,692 | $171 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $5,198 | $124 |
| Long return visit (40+ min) | 49 | $5,137 | $99 |
| Return visit (30+ min) | 36 | $4,542 | $95 |
| Hemodialysis procedure with physician evaluation | 36 | $3,585 | $66 |
| Dialysis procedure including 1 evaluation | 14 | $3,094 | $79 |
| New patient visit (45+ min) | 17 | $2,366 | $139 |
| Long return visit (40+ min) | 15 | $2,325 | $137 |
| New patient visit (45+ min) | 19 | $2,216 | $117 |
| New patient visit (60+ min) | 14 | $2,132 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,887 | $94 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,363 | $91 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 29 | $1,137 | $36 |
| Short return visit (20+ min) | 20 | $798 | $40 |
2018: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $12,093 | $65 |
| Hemodialysis procedure with physician evaluation | 54 | $8,108 | $63 |
| Return visit (30+ min) | 63 | $6,807 | $63 |
| Dialysis procedure including 1 evaluation | 19 | $4,608 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,300 | $122 |
| Return visit (30+ min) | 19 | $2,614 | $101 |
| New patient visit (45+ min) | 17 | $1,960 | $115 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,707 | $90 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 31 | $1,574 | $35 |
| Long return visit (40+ min) | 14 | $1,381 | $92 |
| Short return visit (20+ min) | 18 | $737 | $39 |
2017: 12 services
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $8,701 | $167 |
| Hemodialysis procedure with physician evaluation | 52 | $6,696 | $64 |
| Return visit (30+ min) | 57 | $6,304 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $5,442 | $65 |
| Dialysis procedure including 1 evaluation | 19 | $4,521 | $78 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 55 | $3,598 | $35 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 34 | $3,050 | $90 |
| Return visit (30+ min) | 20 | $2,825 | $101 |
| Long return visit (40+ min) | 18 | $2,092 | $100 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,075 | $122 |
| New patient visit (45+ min) | 14 | $1,500 | $107 |
| Short return visit (20+ min) | 28 | $1,324 | $44 |
2016: 12 services
| Hemodialysis procedure with physician evaluation | 56 | $7,889 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $7,652 | $64 |
| Return visit (30+ min) | 62 | $6,488 | $66 |
| Dialysis services, 1 physician visit per month (20 years or older) | 12 | $3,892 | $169 |
| Return visit (30+ min) | 23 | $3,403 | $90 |
| Short return visit (20+ min) | 67 | $3,190 | $41 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 43 | $3,069 | $35 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 28 | $2,498 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,430 | $121 |
| New patient visit (45+ min) | 17 | $1,961 | $115 |
| Short return visit (20+ min) | 18 | $1,313 | $69 |
| New patient visit (30+ min) | 12 | $814 | $68 |
2015: 9 services
| Hemodialysis procedure with physician evaluation | 72 | $10,182 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $7,709 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $5,876 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $5,252 | $122 |
| Return visit (30+ min) | 52 | $4,637 | $70 |
| New patient visit (45+ min) | 32 | $3,695 | $115 |
| Return visit (30+ min) | 20 | $2,755 | $98 |
| Dialysis procedure including 1 evaluation | 13 | $2,339 | $78 |
| Short return visit (20+ min) | 19 | $864 | $45 |
2014: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 101 | $11,035 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $10,388 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $7,291 | $152 |
| Hospital discharge day management, more than 30 minutes | 77 | $6,332 | $81 |
| Initial hospital observation care per day, typically 70 minutes | 22 | $2,855 | $130 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,234 | $95 |
2013: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $5,368 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $4,059 | $77 |
| Hospital discharge day management, more than 30 minutes | 33 | $2,692 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,394 | $150 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,423 | $102 |
Medicaid work
$13,481 in 2024
Medicaid paid $13,481 for 122 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 49 | $9,989 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 31 | $1,276 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 21 | $1,116 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 21 | $1,101 |
| 2024 | 122 | 4 | 20 | $13,481 |
| 2023 | 261 | 5 | 23 | $18,535 |
| 2022 | 223 | 5 | 20 | $12,304 |
| 2021 | 382 | 6 | 33 | $57,722 |
| 2020 | 359 | 6 | 30 | $45,502 |
| 2019 | 141 | 3 | 21 | $5,762 |
| 2018 | 42 | 1 | 20 | $1,685 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 61 | $9,185 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 152 | $4,942 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 16 | $2,924 |
| Return visit (30+ min) | 16 | $807 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 16 | $678 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 26 | $4,596 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 13 | $3,243 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 116 | $3,208 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 20 | $713 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 48 | $544 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 133 | $28,250 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 95 | $22,989 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 16 | $2,782 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 74 | $1,944 |
| Return visit (30+ min) | 41 | $1,350 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 23 | $408 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 98 | $17,875 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 71 | $15,907 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 42 | $6,936 |
| Return visit (30+ min) | 63 | $2,111 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 55 | $2,074 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 30 | $599 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 90 | $2,830 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 12 | $1,857 |
| Return visit (30+ min) | 39 | $1,075 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 42 | $1,685 |
Drugs they prescribed that Part D paid
$105,215
Pharmacies billed $105,215 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 519) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
419 generic and 100 brand-name prescriptions · $105,215 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Procrit | 31 | $26,695 | $861 |
| Veltassa | 16 | $17,527 | $1,095 |
| Lokelma | 15 | $11,714 | $781 |
| Sevelamer Carbonate | 19 | $9,090 | $478 |
| Retacrit | 13 | $1,862 | $143 |
See all 15 drugs
| Procrit | 31 | $26,695 | $861 |
| Veltassa | 16 | $17,527 | $1,095 |
| Lokelma | 15 | $11,714 | $781 |
| Sevelamer Carbonate | 19 | $9,090 | $478 |
| Retacrit | 13 | $1,862 | $143 |
| Calcium Acetate | 22 | $1,653 | $75 |
| Olmesartan Medoxomil | 34 | $1,055 | $31 |
| Calcitriol | 23 | $569 | $25 |
| Losartan | 57 | $525 | $9 |
| Amlodipine Besylate | 44 | $291 | $7 |
| Torsemide | 15 | $277 | $18 |
| Carvedilol | 30 | $259 | $9 |
| Lisinopril | 28 | $189 | $7 |
| Furosemide | 23 | $147 | $6 |
| Allopurinol | 23 | $143 | $6 |
Year by year
| 2024 | 519 | 103 | 0% (0) | 19% | $105,215 |
| 2023 | 643 | 103 | 0% (0) | None | $80,148 |
| 2022 | 675 | 108 | 0% (0) | None | $109,759 |
| 2021 | 802 | 127 | 0% (0) | None | $96,305 |
| 2020 | 843 | 127 | 0% (0) | None | $76,547 |
| 2019 | 727 | 121 | None | 14% | $45,877 |
| 2018 | 594 | 79 | 0% (0) | None | $87,748 |
| 2017 | 508 | 84 | 0% (0) | None | $81,300 |
| 2016 | 557 | 74 | None | None | $27,356 |
| 2015 | 175 | 48 | 0% (0) | 10% | $4,017 |
| 2014 | 80 | 39 | None | None | $2,356 |
| 2013 | 93 | 32 | None | None | $5,267 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Farxiga | 20 | $14,201 | $710 |
| Retacrit | 46 | $10,558 | $230 |
| Sevelamer Carbonate | 15 | $7,699 | $513 |
| Calcium Acetate | 31 | $3,119 | $101 |
| Potassium Citrate Er | 14 | $1,306 | $93 |
| Amlodipine Besylate | 70 | $1,117 | $16 |
| Losartan | 60 | $1,015 | $17 |
| Carvedilol | 52 | $828 | $16 |
| Hydralazine | 24 | $761 | $32 |
| Olmesartan Medoxomil | 19 | $727 | $38 |
| Calcitriol | 34 | $656 | $19 |
| Furosemide | 53 | $554 | $10 |
| Valsartan | 12 | $516 | $43 |
| Allopurinol | 30 | $472 | $16 |
| Lisinopril | 25 | $440 | $18 |
| Torsemide | 16 | $413 | $26 |
| Chlorthalidone | 13 | $384 | $30 |
| Clonidine | 16 | $195 | $12 |
2022: 17 drugs
| Sevelamer Carbonate | 22 | $12,971 | $590 |
| Epogen | 15 | $10,690 | $713 |
| Retacrit | 26 | $4,930 | $190 |
| Calcium Acetate | 21 | $2,849 | $136 |
| Amlodipine Besylate | 83 | $1,168 | $14 |
| Carvedilol | 62 | $1,089 | $18 |
| Losartan | 75 | $1,060 | $14 |
| Tacrolimus | 12 | $957 | $80 |
| Hydralazine | 23 | $823 | $36 |
| Furosemide | 53 | $660 | $12 |
| Chlorthalidone | 21 | $514 | $24 |
| Calcitriol | 27 | $477 | $18 |
| Torsemide | 18 | $401 | $22 |
| Atorvastatin | 12 | $388 | $32 |
| Allopurinol | 32 | $329 | $10 |
| Lisinopril | 15 | $312 | $21 |
| Olmesartan Medoxomil | 13 | $311 | $24 |
2021: 18 drugs
| Epogen | 28 | $24,062 | $859 |
| Veltassa | 13 | $12,821 | $986 |
| Sevelamer Carbonate | 24 | $12,668 | $528 |
| Procrit | 13 | $3,083 | $237 |
| Retacrit | 14 | $2,570 | $184 |
| Potassium Citrate Er | 24 | $1,942 | $81 |
| Calcium Acetate | 26 | $1,908 | $73 |
| Losartan | 75 | $1,186 | $16 |
| Amlodipine Besylate | 109 | $1,064 | $10 |
| Carvedilol | 62 | $1,027 | $17 |
| Doxazosin Mesylate | 34 | $852 | $25 |
| Chlorthalidone | 26 | $816 | $31 |
| Hydralazine | 36 | $785 | $22 |
| Nifedipine Er | 13 | $564 | $43 |
| Calcitriol | 40 | $537 | $13 |
| Allopurinol | 48 | $474 | $10 |
| Furosemide | 53 | $422 | $8 |
| Lisinopril | 19 | $381 | $20 |
2020: 19 drugs
| Veltassa | 17 | $18,106 | $1,065 |
| Epogen | 16 | $5,111 | $319 |
| Sevelamer Carbonate | 16 | $2,865 | $179 |
| Potassium Citrate Er | 19 | $2,385 | $126 |
| Doxazosin Mesylate | 67 | $1,861 | $28 |
| Calcium Acetate | 19 | $1,859 | $98 |
| Chlorthalidone | 38 | $1,446 | $38 |
| Amlodipine Besylate | 127 | $1,064 | $8 |
| Calcitriol | 35 | $1,002 | $29 |
| Losartan | 65 | $906 | $14 |
| Carvedilol | 60 | $864 | $14 |
| Hydralazine | 23 | $558 | $24 |
| Nifedipine Er | 14 | $519 | $37 |
| Lisinopril | 35 | $508 | $15 |
| Tacrolimus | 12 | $442 | $37 |
| Furosemide | 64 | $420 | $7 |
| Allopurinol | 30 | $341 | $11 |
| Atorvastatin | 18 | $252 | $14 |
| Spironolactone | 18 | $141 | $8 |
2019: 14 drugs
| Potassium Citrate Er | 27 | $3,953 | $146 |
| Prosol | 13 | $1,785 | $137 |
| Chlorthalidone | 54 | $1,682 | $31 |
| Amlodipine Besylate | 144 | $1,176 | $8 |
| Doxazosin Mesylate | 33 | $878 | $27 |
| Carvedilol | 59 | $801 | $14 |
| Calcitriol | 25 | $790 | $32 |
| Losartan | 60 | $599 | $10 |
| Tacrolimus | 14 | $583 | $42 |
| Allopurinol | 48 | $578 | $12 |
| Hydralazine | 13 | $421 | $32 |
| Lisinopril | 32 | $280 | $9 |
| Furosemide | 44 | $246 | $6 |
| Spironolactone | 23 | $246 | $11 |
2018: 15 drugs
| Renvela | 18 | $24,560 | $1,364 |
| Sensipar | 12 | $19,579 | $1,632 |
| Aranesp | 11 | $13,117 | $1,192 |
| Prosol | 48 | $5,930 | $124 |
| Potassium Citrate Er | 18 | $3,198 | $178 |
| Procrit | 16 | $2,629 | $164 |
| Chlorthalidone | 34 | $1,467 | $43 |
| Calcitriol | 31 | $758 | $24 |
| Amlodipine Besylate | 101 | $680 | $7 |
| Losartan | 48 | $502 | $10 |
| Lisinopril | 49 | $496 | $10 |
| Allopurinol | 29 | $416 | $14 |
| Potassium Chloride | 17 | $316 | $19 |
| Carvedilol | 28 | $199 | $7 |
| Furosemide | 39 | $181 | $5 |
2017: 11 drugs
| Sensipar | 18 | $19,975 | $1,110 |
| Renagel | 18 | $14,712 | $817 |
| Potassium Citrate Er | 28 | $5,500 | $196 |
| Chlorthalidone | 27 | $1,364 | $51 |
| Allopurinol | 40 | $651 | $16 |
| Calcitriol | 23 | $639 | $28 |
| Amlodipine Besylate | 64 | $555 | $9 |
| Lisinopril | 25 | $250 | $10 |
| Losartan | 33 | $250 | $8 |
| Carvedilol | 25 | $183 | $7 |
| Furosemide | 30 | $131 | $4 |
2016: 14 drugs
| Potassium Citrate Er | 34 | $4,457 | $131 |
| Chlorthalidone | 30 | $1,285 | $43 |
| Calcitriol | 47 | $909 | $19 |
| Calcium Acetate | 13 | $580 | $45 |
| Amlodipine Besylate | 70 | $496 | $7 |
| Carvedilol | 60 | $430 | $7 |
| Losartan | 45 | $413 | $9 |
| Hydralazine | 14 | $349 | $25 |
| Potassium Chloride | 12 | $272 | $23 |
| Doxazosin Mesylate | 11 | $266 | $24 |
| Allopurinol | 17 | $249 | $15 |
| Lisinopril | 38 | $242 | $6 |
| Furosemide | 37 | $195 | $5 |
| Sertraline | 14 | $35 | $3 |
2015: 5 drugs
| Losartan | 20 | $173 | $9 |
| Lisinopril | 26 | $102 | $4 |
| Furosemide | 15 | $80 | $5 |
| Amlodipine Besylate | 15 | $71 | $5 |
| Carvedilol | 14 | $63 | $5 |
2013: 1 drug
| Lisinopril | 17 | $84 | $5 |
Money from drug and device companies
$194 in 2025
| 2025 | 3 | 3 | None | $194 |
| 2024 | 6 | 12 | $3,068 | $5,391 |
| 2023 | 1 | 3 | $1,500 | $2,808 |
| 2022 | 1 | 9 | $3,600 | $4,664 |
| 2021 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Apellis Pharmaceuticals | Empaveli | $141 | 1 payment
|
| Amgen | Tavneos | $29 | 1 payment
|
| Calliditas Therapeutics US | Tarpeyo | $23 | 1 payment
|
See all 3 published payments
| Apellis Pharmaceuticals | Meals · 2025-09-22 | Empaveli | $141 |
| Amgen | Meals · 2025-09-11 | Tavneos | $29 |
| Calliditas Therapeutics US | Meals · 2025-07-17 | Tarpeyo | $23 |
See earlier years (2024, 2023, 2022, 2021)
2024: $5,391
| Apellis Pharmaceuticals | Empaveli | $3,068 | 1 payment
|
| Travere Therapeutics | None | $1,725 | 5 payments
|
| Aurinia Pharma U.S. | Lupkynis | $297 | 3 payments
|
| Amgen | Krystexxa | $145 | 1 payment
|
| Novartis Pharmaceuticals | Fabhalta | $127 | 1 payment
|
| GlaxoSmithKline | Benlysta | $29 | 1 payment
|
2023: $2,808
| Travere Therapeutics | None | $2,808 | 3 payments
|
2022: $4,664
| Travere Therapeutics | None | $4,664 | 9 payments
|
2021: $125
| Ablative Solutions | None | $125 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Calliditas Therapeutics US Inc. · Nefecon · 2025 | Their institution | $20,998 |
Professional record
- NPI
- 1154579969
- Licence
- CA A134411, MO 2008014630California A134411: Current · expires 2028-09-30
- Trained
- University of Missouri, Kansas City, School of Medicine, 2007
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-09-04
- NPI last updated
- 2024-04-18
- NPI record certified
- 2024-04-18
This is when the NPI record was last certified, not a medical board exam.